Australian neuroscience in 2006--highlights from the scientific meeting.
The annual meeting of the Australian Neuroscience Society (ANS) was held in Sydney, Australia, January 31-February 3, 2006. The main meeting was preceded by four satellite meetings. This report predominantly considers some of the drug targets highlighted at the ANS meeting, and at the Dementia, Ageing and Neurodegenerative Diseases Group (DANDIS) satellite. The targets considered are for neurodegeneration, stroke and neuroprotection. Also, various receptors, transporters and channels are considered as therapeutic targets in neuroscience.
Doggrell
Sheila A
SA
Division of Health Practice, Auckland University of Technology-Akoranga Campus, Northcote, Auckland, New Zealand. s_doggrell@yahoo.com
D000375:Aging / Q000502:physiology; D003704:Dementia / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D015394:Molecular Structure; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000737:chemistry / Q000627:therapeutic use*; D009488:Neurosciences; D020521:Stroke / Q000188:drug therapy / Q000503:physiopathology
D018696:Neuroprotective Agents